Bay Colony Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $964K | Sell |
13,973
-437
| -3% | -$30.2K | 0.13% | 148 |
|
|
2025
Q1 | $999K | Buy |
14,410
+3,656
| +34% | +$253K | 0.15% | 144 |
|
|
2024
Q4 | $925K | Sell |
10,754
-2,923
| -21% | -$251K | 0.14% | 152 |
|
|
2024
Q3 | $1.63M | Sell |
13,677
-2,261
| -14% | -$269K | 0.25% | 90 |
|
|
2024
Q2 | $2.27M | Sell |
15,938
-1,436
| -8% | -$205K | 0.38% | 54 |
|
|
2024
Q1 | $2.23M | Buy |
17,374
+6,778
| +64% | +$870K | 0.39% | 49 |
|
|
2023
Q4 | $1.1M | Buy |
10,596
+4,663
| +79% | +$482K | 0.22% | 103 |
|
|
2023
Q3 | $540K | Buy |
5,933
+1,689
| +40% | +$154K | 0.13% | 162 |
|
|
2023
Q2 | $343K | Buy |
4,244
+550
| +15% | +$44.5K | 0.08% | 214 |
|
|
2023
Q1 | $292K | Buy |
+3,694
| New | +$292K | 0.08% | 234 |
|